The Clinical Impact of Isolation of Two Different Bacteria in Urinary Cultures

NCT ID: NCT01060956

Last Updated: 2011-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

81 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2011-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether identification of two different bacteria in urine culture of patients with indwelling catheter has a clinical impact - change in antibiotic, duration of antibiotic, days to clinical resolution and length of stay in hospital.

The microbiology laboratory will randomized urine cultures with two bacteria from indwelling catheter to either reporting identity and susceptibility of the bacteria or reporting "mixed growth".

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Reporting on two bacteria in urine culture

The microbiology laboratory will report on the isolation and susceptibilities of two different bacteria in urine culture

Group Type ACTIVE_COMPARATOR

reporting of two different bacteria in urine culture

Intervention Type OTHER

reporting of two different bacteria in urine culture

reporting "mixed growth"

The microbiology laboratory will report on mixed growth in urine culture

Group Type PLACEBO_COMPARATOR

reporting "mixed growth" on urine culture

Intervention Type OTHER

reporting "mixed growth" on urine culture

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

reporting of two different bacteria in urine culture

reporting of two different bacteria in urine culture

Intervention Type OTHER

reporting "mixed growth" on urine culture

reporting "mixed growth" on urine culture

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults hospitalized with indwelling urinary catheter in growth of two bacteria in urine culture

Exclusion Criteria

* Positive blood cultures or no blood cultures taken
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaare Zedek Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shaare Zedek Medical Center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amos M Yinnon, MD, Prof

Role: PRINCIPAL_INVESTIGATOR

Hebrew university, Jerusalem, Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UTI1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gentamicin Bladder Instillation on CAUTI
NCT06332040 RECRUITING PHASE4